Trastuzumab deruxtecan (T-DXd) in patients with human epidermal growth factor receptor 2 (HER2)-expressing salivary duct carcinoma: Subgroup analysis of two phase 1 studies Meeting Abstract
| Authors: | Bando, H.; Kinoshita, I.; Modi, S.; Tsurutani, J.; Bang, Y. J.; Iwata, H.; Sato, Y.; Nakatani, S.; Lee, C. C.; Sugihara, M.; Okuda, Y.; Takahashi, S. |
| Abstract Title: | Trastuzumab deruxtecan (T-DXd) in patients with human epidermal growth factor receptor 2 (HER2)-expressing salivary duct carcinoma: Subgroup analysis of two phase 1 studies |
| Meeting Title: | 2021 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2021 Jun 4-8 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-05-20 |
| Language: | English |
| ACCESSION: | WOS:000708120603270 |
| DOI: | 10.1200/JCO.2021.39.15_suppl.6079 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 6079 -- Source: Wos |
